Skip to main content
Caplight Logo









INBRAIN Neuroelectronics

INBRAIN Neuroelectronics

Private
BarcelonaHealthcare & Life Scienceshttps://inbrain-neuroelectronics.com/

Last Round

Grant

May 6, 2025

Total Funding Raised

$72.22M

Company Overview

INBRAIN Neuroelectronics is a medical technology company that develops graphene-based, AI-powered brain-computer interface (BCI) therapies for neurological conditions such as Parkinson's and epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Medical AI, Sensors, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIgraphene bioelectronicsneurotechneuromodulationbrain implantneural interfaceclosed-loop neuromodulationadaptive neurostimulationbrain decodingpersonalized neurostimulationAI medical platformParkinson's disease therapyepilepsy therapymedical deviceperipheral nerve applications

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INBRAIN Neuroelectronics Comparables

Compare INBRAIN Neuroelectronics with similar companies based on industry and business-model similarity.

INBRAIN Neuroelectronics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precision Neuroscience
86%
Axoft
83%
Neurosoft Bioelectronics
81%

INBRAIN Neuroelectronics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 6, 2025
Series BOct 29, 2024
Series AMar 30, 2021
SeedJun 29, 2020

Key People

Founding team and executive leadership

Jose Antonio Garrido

Founder And Chief Scientific Officer

Founding Team

Carolina Aguilar

Chief Executive Officer & Co-Founder

Founding Team

Jurriaan Bakker

Chief Technology Officer

Executive Team

Jerome Crocco

Chief Operations Officer, Chief Operating Officer

Executive Team

INBRAIN Neuroelectronics Investors

Notable investors and investment history

INBRAIN Neuroelectronics investors
InvestorRounds
Asabys PartnersSeries B, Series A, Seed
Alta Life SciencesSeries A, Seed
ICF Venture Tech IISeries A
AvançsaSeries B
Ysios CapitalSeed
Fond-ICO Next TechSeries B
imec.xpandSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2026

    Job posting discloses an ongoing 4-year collaboration between its subsidiary INNERVIA and Merck KGaA to develop therapies for the peripheral nervous system.

  • Mar 1, 2026

    Collaboration to advance neuroelectronic therapies.

INBRAIN Neuroelectronics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INBRAIN Neuroelectronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INBRAIN Neuroelectronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range126
Year Founded2019
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?